Aurinia Pharmaceuticals Ownership | Who Owns Aurinia Pharmaceuticals?
Aurinia Pharmaceuticals Ownership Summary
Aurinia Pharmaceuticals is owned by 40.12% institutional investors, 7.16% insiders, and 52.72% retail investors. Armistice capital is the largest institutional shareholder, holding 7.73% of AUPH shares. iShares Russell 2000 ETF is the top mutual fund, with 2.54% of its assets in Aurinia Pharmaceuticals shares.
AUPH Ownership Benchmark
Type | Name | % Inst | % Insiders | % Retail |
---|---|---|---|---|
Stock | Aurinia Pharmaceuticals | 40.12% | 7.16% | 52.72% |
Sector | Healthcare Stocks | 88.01% | 8.90% | 3.09% |
Industry | Biotech Stocks | 109.70% | 8.77% | -18.47% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
Holder | Shares | % Holding | Value |
---|---|---|---|
Armistice capital | 11.14M | 7.73% | $63.59M |
Blackrock | 9.27M | 6.44% | $52.94M |
Blackrock funding, inc. /de | 8.95M | 6.26% | $80.39M |
Nea management company | 3.97M | 2.76% | $22.67M |
State street | 2.88M | 2.00% | $16.45M |
Tang capital management | 2.78M | 1.93% | $15.87M |
Geode capital management | 1.76M | 1.23% | $15.84M |
Goldman sachs group | 1.75M | 1.22% | $15.73M |
Vanguard group | 1.73M | 1.21% | $15.53M |
Nuveen asset management | 1.49M | 1.04% | $13.40M |
Top Institutional Shareholders by % of Total Assets
Holder | Shares | % Assets | Value |
---|---|---|---|
Nea management company | 3.97M | 1.71% | $22.67M |
Tang capital management | 2.78M | 1.62% | $15.87M |
Armistice capital | 11.14M | 0.80% | $63.59M |
Ironwood investment management | 94.31K | 0.42% | $846.90K |
Virtus investment advisers | 82.83K | 0.40% | $472.95K |
Rock springs capital management lp | 1.18M | 0.20% | $6.74M |
Virtus etf advisers | 61.56K | 0.17% | $351.51K |
Virtus fund advisers | 6.79K | 0.15% | $38.76K |
Highmark wealth management | 21.70K | 0.11% | $194.83K |
Sunbelt securities | 160.22K | 0.09% | $914.88K |
Top Buyers
Holder | Shares | % Assets | Change |
---|---|---|---|
Arrowstreet capital, limited partnership | 1.08M | 0.01% | 1.08M |
Tang capital management | 2.78M | 1.62% | 729.50K |
Blackrock | 9.27M | 0.00% | 609.18K |
Jpmorgan chase | 927.30K | 0.00% | 424.48K |
Renaissance | 700.90K | 0.01% | 214.20K |
Top Sellers
Holder | Shares | % Assets | Change |
---|---|---|---|
Armistice capital | 11.14M | 0.80% | -1.12M |
Schroder investment management group | - | - | -997.22K |
Goldman sachs group | 1.75M | 0.00% | -655.85K |
683 capital management | - | - | -400.00K |
Group one trading | - | - | -377.32K |
New Positions
Holder | Shares | % Assets | Change | Value |
---|---|---|---|---|
Arrowstreet capital, limited partnership | 1.08M | 0.01% | 1.08M | $9.66M |
Qube research | 195.76K | 0.00% | 195.76K | $1.76M |
Pdt partners | 171.35K | 0.09% | 171.35K | $978.40K |
Norges bank | 114.05K | 0.00% | 114.05K | $651.20K |
Virtus investment advisers | 82.83K | 0.40% | 82.83K | $472.95K |
Sold Out
Holder | Change |
---|---|
Vima | -25.00 |
Nelson, van denburg & campbell wealth management group | -26.00 |
Walleye trading | -300.00 |
Spectrum wealth counsel | -334.00 |
Lowe wealth advisors | -531.00 |
Institutional Ownership Trends
Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
---|---|---|---|---|---|---|---|---|---|---|
Sep 30, 2024 | 195 | 7.73% | 57,393,945 | 3.76% | 40 | 2.69% | 83 | -2.35% | 43 | - |
Jun 30, 2024 | 180 | -8.63% | 55,314,751 | 0.64% | 38 | 2.61% | 85 | 13.33% | 42 | -32.26% |
Mar 31, 2024 | 197 | -6.19% | 54,961,177 | 3.27% | 38 | 2.78% | 75 | -9.64% | 62 | 1.64% |
Dec 31, 2023 | 210 | -2.78% | 53,221,003 | 5.95% | 37 | 3.00% | 83 | -10.75% | 61 | 22.00% |
Sep 30, 2023 | 216 | -1.37% | 50,234,131 | 0.83% | 35 | 2.88% | 93 | -2.11% | 50 | -9.09% |
Top Mutual Funds Shareholders
Holder | Shares | % Holding | Change |
---|---|---|---|
iShares Russell 2000 ETF | 3.63M | 2.54% | -27.60K |
Fidelity Small Cap Index | 1.37M | 0.96% | -3.10K |
Nuveen Quant Small Cap Equity R6 | 1.10M | 0.77% | - |
International Biotechnology Ord | 997.22K | 0.70% | - |
iShares Russell 2000 Growth ETF | 881.08K | 0.62% | -4.13K |
State St Russell Sm/Mid Cp® Indx NL Cl C | 827.90K | 0.58% | -72.30K |
iShares Biotechnology ETF | 815.09K | 0.57% | -1.73K |
Vanguard Russell 2000 ETF | 636.38K | 0.44% | 6.36K |
State St Russell Sm Cap® Indx SL Cl I | 464.95K | 0.32% | - |
Vanguard Health Care ETF | 395.46K | 0.28% | -4.09K |
Recent Insider Transactions
Date | Name | Role | Activity | Value |
---|---|---|---|---|
Dec 05, 2024 | TANG KEVIN | - | Buy | $2.67M |
Dec 09, 2024 | TANG KEVIN | - | Buy | $4.54M |
Dec 06, 2024 | TANG KEVIN | - | Buy | $3.60M |
Nov 11, 2024 | Bailey Jeffrey Allen | - | Sell | $38.42K |
Nov 11, 2024 | Smith Karen L. | - | Sell | $44.18K |
Insider Transactions Trends
Date | Buy | Sell |
---|---|---|
2024 Q4 | 3 | 2 |
2024 Q3 | - | 1 |
2024 Q2 | - | 5 |
2024 Q1 | - | 8 |
2023 Q3 | - | - |
AUPH Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools